Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- Anatomy of Success: Green Mountain Coffee
- The Mega-Rally Rolls On
- RTI: Prediction Contest: S&P 500 on Dec. 31st
- Biotechnology ETF Investing 101
- 3 Dividend Stocks at Reasonable Prices
- AWS 5/21: The Beginning of the End for QE
- PFP 5/21: Below the Surface
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/21/2013
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 6.93% |
| FEDERAL MOGU | FDML | 6.24% |
| NATUS MEDICA | BABY | 5.55% |
| NEW ORIENTAL | EDU | 5.40% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Company Description
OMNOVA Solutions makes emulsion polymers and other specialty chemicals that have decorative and functional uses. The company serves commercial, industrial and residential markets.
Record Quarter
On Jun 29 OMNOVA reported quarterly results that showed net income of just over $15 million, triple the level one year ago. Earnings per share broke down to 29 cents, beating the Zacks Consensus Estimate by a dime.
The company saw a very nice 40% increase in sales, to $65 million, driven by higher pricing and more volume.
Estimates Climbing
Following the news, analysts revised their full-year estimates. OMNOVA is expected to earn 92 cents this year, up 8 cents. Next year's estimates are averaging 96 cents, a 3 cent improvement.
Given the 68 cents earned last year, the year-over-year growth rates are now 36% and 4%, respectively.
Valuation
Shares of OMN are trading at a nice discount. Currently you can own a piece of OMNOVA for less than 9 times forward earnings. The PEG ratio is a miniscule 0.2 times.
The Chart
Even with the great quarterly report, shares are still hitting resistance at this level. However, with momentum going the right way the stock has a good chance to break out and set a new 52-week high.
Read the April 1st Feature Here
Bill Wilton is the Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Growth Trader service
Last Week's Aggressive Growth Zacks Rank Buy Stocks
Local.com Corp (LOCM) raised its full-year outlook and analysts followed suit. Shares are trading at a nice multiple and at a good entry point. Read Full Article.
Medifast, Inc. (MED) analysts are raising estimates after a record setting quarter. The stock should see more investor attention after being added to a well known index. Read Full Article.
CarMax (KMX) was recently added to the S&P 500 after posting its seventh consecutive earnings surprise. Read Full Article.
Pier 1 Imports, Inc (PIR) analysts are raising estimates after the company posted a surprise profit last quarter. Shares are trading at a bargain and there is plenty of growth over the next few years. Read Full Article.
Read the full Snapshot Report on OMN